SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

TSLA is trending as investors digest recent earnings and weigh the company's future prospects amid discussions around revenue, margins, and ambitious projects like Optimus and robotaxis. Community sentiment appears divided, with some expressing concerns about valuation and execution, while others remain optimistic about Tesla's long-term vision and innovative potential in AI and energy. The stock's volatile after-hours movement reflects this uncertainty as the community debates its next direction.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to discussions around potential government investments in quantum computing firms, spurred by a recent Wall Street Journal report. The community is debating the impact of this news, with some predicting a short squeeze and others expressing skepticism about the long-term value and potential for government intervention to inflate the stock. Concerns about the company's financials and comparisons to other speculative sectors are also prevalent.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

QBTS is trending as the Trump administration reportedly explores taking equity stakes in quantum computing firms, sparking excitement and debate among investors. Community members are discussing potential short squeezes and the impact of government investment on the legitimacy of quantum technology. Some caution against hype, citing concerns about scalability and the company's niche market position.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending as the community discusses the potential impact of new quantum computing performance benchmarks and related implications for the sector. Bearish sentiment and potential double top patterns are being weighed against government funding talks and possible short squeezes. Some traders express skepticism, citing dilution concerns and the company's cash burn rate.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending due to positive reactions to its quantum computing advancements, particularly a partnership with HSBC that improved bond-trading predictions; the community highlights IBM's leadership in quantum and AI, with some seeing it as undervalued despite mixed reactions to earnings and Red Hat's growth.

MUSE

$MUSE is trending as traders highlight its low market cap and limited supply, sparking discussions about potential for significant price movement. The community is drawing comparisons to other low-cap cryptos that have experienced substantial pumps, speculating whether $MUSE could be next. Some are also discussing its NFT trading activity and ATH of $125, while others believe a large volume surge could trigger a major breakout.

Imperial Petroleum, Inc. is a ship-owning company, which engages in providing petroleum products and crude oil seaborne transportation services. It offers international seaborne transportation services to oil producers, refineries, and commodities traders. It has a fleet of three medium range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil and jet fuel, as well as edible oils and chemicals, and one Aframax tanker which is used for carrying crude oil. The company was founded on May 14, 2021 and is headquartered in Athens, Greece.

Imperial Petroleum Inc

IMPP is trending as traders discuss its potential sympathy play amid rising oil prices and geopolitical tensions. Community members are actively monitoring fleet utilization, spot rates, and potential for a short squeeze due to high short interest. Some investors express frustration with the company's management and historical performance despite a strong balance sheet.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies is trending as the company has demonstrated a quantum-safe implementation of Bitcoin, which could protect against future quantum computing threats. Community members are discussing the potential impact on Bitcoin and the broader crypto market, along with BTQ's low market cap relative to other quantum computing stocks. Bullish sentiment is growing, with some investors highlighting insider ownership and potential government interest in quantum security.

On a mission to onboard the next 1,000,000 degens to @Ethereum.  Launched stealth with no presale, zero taxes, LP burnt and contract renounced,   US Degen Index 6900 is a memecoin. It is completely useless and fulfills no purpose or utility. Partaking in the community in any way has no expectation of profit and is done for entertainment purposes only.   That's the US Degen Index 6900. Each token is meticulously and mathematically designed to profit from variation. At the DXY, utility IS volatility.  $DXY is the most shilled ticker on Twitter from all stocks and crypto related accs. MILLIONS of tweets have been sent out about the US dollar and it's impact on markets.

US Degen Index 6900

The US Degen Index 6900 ($DXY) is trending as traders discuss its potential weakness and path toward lower levels, with bounces expected to fail. Community members are pointing to Elliott Wave analysis and "blue box" strategies to identify selling opportunities. Broader market context includes discussion of the dollar's dominance, potential impacts from inflation data, and its relationship with gold and other assets.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ ($LAES) is trending as traders discuss a potential short squeeze, fueled by overnight price action and speculation around government investments in quantum computing firms; the community is weighing the impact of recent stock offerings against the company's technology and potential for growth in the quantum security sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study

Sanofi's efdoralprin alfa meets all key endpoints in a global phase II study, showing potential as a first restorative recombinant therapy for AATD.

Will Declining Gardasil Sales Ail MRK's Top Line in Q3 Earnings?

Merck faces a sharp Gardasil slowdown as weak demand in China and Japan affects sales of the vaccine.

Shares of Revolution Medicines, Disc Medicine, and Regeneron Pharmaceuticals rose in after-hours trading on Thursday after the U.S. Food and Drug Administration (FDA) announced the first group of drugs selected for expedited review under its new National Priority Voucher pilot program.In after-hours trading on Thursday,&nbsp;<a href="https://stocktwits.com/symbol/RVMD">Revolution Medicines</a> jumped 9%,&nbsp;<a href="https://stocktwits.com/symbol/IRON">Disc Medicine</a> surged 17%, and&nbsp;<a href="https://stocktwits.com/symbol/REGN">Regeneron Pharmaceuticals</a> edged up 0.1%.FDA Names 9 Drugs For Accelerated ReviewThe FDA said nine products have been chosen for the fast-track review process, which shortens decision timelines from the usual 10–12 months to just one or two months once a complete application is filed.The selected drugs include Merck KGaA’s fertility treatment Pergoveris, Sanofi’s Type 1 diabetes therapy teplizumab, Regeneron’s gene therapy DB-OTO for congenital deafness, and ketamine for domestic manufacturing of a general anesthetic.&nbsp;Also on the list are Revolution Medicines’ RMC-6236 for pancreatic cancer, Disc Medicine’s bitopertin for porphyria, Achieve Life Sciences’ cytisinicline for nicotine vaping addiction, Dompe’s cenegermin-bkbj for blindness, and Augmentin XR for domestic manufacturing of a common antibiotic.FDA Commissioner Highlights Expedited Review EffortFDA Commissioner Marty Makary said the initiative could shorten FDA decision times from a year to "a matter of weeks” by moving promising or high-impact therapies to the front of the review line.Makary said some of the drugs selected for vouchers, including one that uses ketamine as a general anesthetic, will be manufactured in the United States. He described Regeneron’s DB-OTO, a gene therapy for congenital deafness, as “an exciting treatment,” noting that “some of these kids got normal hearing from this amazing treatment.”He added that this is just the first round of vouchers, with additional selections expected in the coming weeks.How Stocktwits Traders Reacted To FDA’s Fast-Track ListOn Stocktwits, retail sentiment toward Revolution Medicines was ‘extremely bullish’ with ‘extremely high’ message volume, while Disc Medicine saw ‘neutral’ sentiment amid similarly ‘extremely high’ activity, and Regeneron registered ‘neutral’ sentiment with ‘normal’ engagement levels.One&nbsp; user said they expect Regeneron shares to climb steadily, projecting the stock could reach the $800-$900 range within two years.&nbsp;<stembedurl>https://stocktwits.com/Iwannagofast1/message/632653980</stembedurl>Another bullish trader suggested Revolution Medicines could be an attractive takeover candidate, potentially fetching twice its current value.<stembedurl>https://stocktwits.com/ChessGM/message/632555600</stembedurl>So far this year, Revolution Medicines shares have gained 14%, Disc Medicine is up 17%, while Regeneron has declined 20%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the FDA (United States Food and Drug Administration) logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program

The FDA’s new National Priority Voucher pilot helps with faster drug reviews, cutting timelines from nearly a year to weeks.

Equity

EVOQ Therapeutics Announces Collaboration and License Agreement with Sanofi

EVOQ Therapeutics Announces Collaboration and License Agreement with Sanofi EVOQ Therapeutics Announces Collaboration and License Agreement with Sanofi PR Newswire CHICAGO, Oct. 16, 2025 CHICAGO...

REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss (Revised)

Regeneron's DB-OTO gene therapy shows hearing gains in nearly all CHORD study participants, with durable and meaningful improvements.

TEVA Gets FDA Nod for Uzedy Label Expansion in Bipolar I Disorder

Teva secures FDA approval for Uzedy label expansion to treat adults with bipolar I disorder.

REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss 

Top Research Reports for Walmart, Sony & Citigroup

Today's Research Daily features new research reports on 16 major stocks, including Walmart, Sony, and Citigroup, as well as a micro-cap stock, AgEagle. 

RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes

Revvity partners with Sanofi to launch a scalable diagnostic test for early T1D detection, expanding its reach beyond rare diseases.

Regeneron Gets FDA Nod for Label Expansion of Oncology Drug Libtayo 

REGN secures FDA approval to expand Libtayo's label for high-risk skin cancer, boosting its oncology momentum amid Eylea sales pressure.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Current Price	$49.99
Prev Close	$49.66
Open	$49.97
Dividend Yield	3.31%
50-Day Moving Average	$48.59
Beta	0.26
Avg. Volume	4.18M
PE Ratio	12.43

52-Week High	$60.12
52-Week Low	$44.62
Market Capitalization	$105.92B
EPS (Annual)	$2.40
Price to Book	1.48
Revenue Per Employee	$525,340.04
Enterprise Value/EBITDA	N/A

SNY
Sanofi-Aventis

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SNY News

SNYSanofi-Aventis